Skip to main content
. 2025 Jul 22;17(15):2414. doi: 10.3390/cancers17152414
ADT androgen deprivation therapy
ARPI androgen receptor pathway inhibitor
GnRH gonadotropin-releasing hormone
HF heart failure
MACE major adverse cardiovascular event
mCRPC metastatic castration-resistant prostate cancer
NHIRD National Health Insurance Research Database
PCa prostate cancer
RSF random survival forest
VIMP variable importance